Neurocore Hunts for the Elusive ADHD Treatment

Attention Deficit Hyperactivity Disorder (ADHD) is a serious problem that plagues the US. While it is difficult to pinpoint exactly when the disease begins its course, most symptoms become clear during childhood. ADHD is unique in that some professionals in the medical community are unsure if the condition is a medical disorder at all. Their argument is that the symptoms displayed are typical of children and classifying hyperactivity as a mental disorder is a slippery slope leading to the lumping of nearly every facet of childhood behavior into a medical condition of some sort.

Thus, Neurocore has their work cut out for them. While Attention Deficit Hyperactivity Disorder is recognized by the DSM-IV, the fact that its validity as a medical condition is questioned, make tracking down the cause that much more difficult. Read more about Neurocore at glassdoor.com.

Certain studies involving twins have suggested that the disorder is present seventy-five percent of the twin of a diagnosed ADHD child. This would point to a clear genetic component to the disorder. Other studies have shown that fetal alcohol spectrum disorders can include symptoms that indicate the presence of ADHD. Scientists from the National Collaborating Centre for Mental Health have suggested that Attention Deficit Hyperactivity Disorder is a result of an education system poorly suited to deal with the specific needs of children, leading them to display such symptoms.

With all these theories floating around, Neurocore has a daunting job indeed. Their research, in tandem with many other clinical researchers studying this condition, have indicated that a plethora of treatments are effective in curbing the symptoms of Attention Deficit Hyperactivity Disorder. Most physicians will prescribe a stimulant for a child with ADHD. The favored medication is methylphenidate (Ritalin), however there are a number of non-stimulant pharmaceuticals that can be administered to great effect as well such as guanfacine, atomoxetine, clonidine, and bupropion. Even a something as simple as a cup of coffee has shown positive results. See more information at Linkedin about Neurocore.

Dietary constraints are another option for patients who want to avoid expensive prescriptions or mood-altering drugs. A tendency to avoid the over-abundance of fatty-acids as well as staying away from certain food-coloring agents has shown to be an effective means of treating Attention Deficit Hyperactivity Disorder in patients during a meta-study in 2013.

The task of finding the root, and then a treatment for this condition is a large one, but Neurocore continues to lead the field it their search.

Visit: https://www.facebook.com/NeurocoreLivonia/

Leave a Reply

Your email address will not be published. Required fields are marked *